See All Slides - tctmd.com

Slides

Presentation TCT 2012

Preclinical Review: Experimental Considerations and Challenges for TAVR Validation

Presenter: Stanton Rowe

October 23, 2012

Presentation TCT 2012

CTA Imaging and Prognosis: From Calcium Scoring to Coronary Anatomy

Presenter: Szilard Voros

October 23, 2012

Presentation TCT 2012

TCT-23. Detection by Near-infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients with Acute ST-Segment Elevation Myocardial Infarction

Presenter: Ryan Madder

October 23, 2012

Presentation TCT 2012

TCT-58. Effects of Mechanical Thrombectomy and Intracoronary Abciximab on Coronary Flow and Infarct Size During Primary PCI: Analysis from the INFUSE-AMI Trial

Presenter: Jan-Henk Dambrink

October 23, 2012

Presentation TCT 2012

BioMime (Meril Life Sciences) Program Update

Presenter: Ashok Seth

October 23, 2012

Presentation TCT 2012

Follow the (Lack of) Evidence: Medical Therapy and CRT!

Presenter: Allan Schwartz

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Presenter: Jeffrey Kuvin

October 23, 2012

Presentation TCT 2012

Do Statins and Other Therapies Alter Vulnerable Plaque Characteristics? Insights from Imaging

Presenter: Pedro Moreno

October 23, 2012

Presentation TCT 2012

Viability Testing, Clinical Decision Making(2)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Presenter: Ajay Kirtane

October 23, 2012

Advertisement

Slides

Preclinical Review: Experimental Considerations and Challenges for TAVR Validation

CTA Imaging and Prognosis: From Calcium Scoring to Coronary Anatomy

TCT-23. Detection by Near-infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients with Acute ST-Segment Elevation Myocardial Infarction

TCT-58. Effects of Mechanical Thrombectomy and Intracoronary Abciximab on Coronary Flow and Infarct Size During Primary PCI: Analysis from the INFUSE-AMI Trial

BioMime (Meril Life Sciences) Program Update

Follow the (Lack of) Evidence: Medical Therapy and CRT!

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Do Statins and Other Therapies Alter Vulnerable Plaque Characteristics? Insights from Imaging

Viability Testing, Clinical Decision Making(2)

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content